potassium iodide has been researched along with HIV Coinfection in 3 studies
Potassium Iodide: An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
potassium iodide : A metal iodide salt with a K(+) counterion. It is a scavenger of hydroxyl radicals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorward, J | 1 |
| Naidoo, J | 1 |
| Moodley, P | 1 |
| Sookrajh, Y | 1 |
| Samsunder, N | 1 |
| Sayed, F | 1 |
| Naicker, N | 1 |
| Fanshawe, T | 1 |
| Drain, PK | 1 |
| Lessells, RJ | 1 |
| Hayward, G | 1 |
| Butler, CC | 1 |
| Garrett, N | 1 |
| Bile, EC | 1 |
| Bachanas, PJ | 1 |
| Jarvis, JN | 1 |
| Maurice, F | 1 |
| Makovore, V | 1 |
| Chebani, L | 1 |
| Jackson, KG | 1 |
| Birhanu, S | 1 |
| Maphorisa, C | 1 |
| Mbulawa, MB | 1 |
| Alwano, MG | 1 |
| Sexton, C | 1 |
| Modise, SK | 1 |
| Bapati, W | 1 |
| Segolodi, T | 1 |
| Moore, J | 1 |
| Fonjungo, PN | 1 |
| Ndoye, AS | 2 |
| Ndiaye, HD | 2 |
| Diallo, M | 2 |
| Diack, A | 2 |
| Coulibaly, K | 2 |
| Lo, G | 2 |
| Kiernan, B | 2 |
| Sène, PY | 2 |
| Ndiaye, O | 2 |
| Ngom, NF | 2 |
| Fall, M | 2 |
| Diop, K | 2 |
| Gueye, SB | 2 |
| Dieng, A | 2 |
| Lejeune, C | 2 |
| Ndour, CT | 2 |
| Kane, CT | 2 |
3 other studies available for potassium iodide and HIV Coinfection
| Article | Year |
|---|---|
Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
Topics: Adult; Female; HIV Infections; HIV-1; Humans; Male; Potassium Iodide; Prospective Studies; RNA, Vira | 2022 |
Accuracy of point-of-care HIV and CD4 field testing by lay healthcare workers in the Botswana Combination Prevention Project.
Topics: Botswana; CD4 Lymphocyte Count; Health Personnel; HIV Infections; Humans; Point-of-Care Systems; Pot | 2023 |
Validation of the point-of-care (POC) technologies Xpert HIV-1 Qual and m-PIMA HIV 1/2 detect for early diagnosis of HIV-1 and HIV-2 in Senegal.
Topics: Child; Early Diagnosis; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant; Infant, Newborn; Infec | 2022 |
Validation of the point-of-care (POC) technologies Xpert HIV-1 Qual and m-PIMA HIV 1/2 detect for early diagnosis of HIV-1 and HIV-2 in Senegal.
Topics: Child; Early Diagnosis; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant; Infant, Newborn; Infec | 2022 |
Validation of the point-of-care (POC) technologies Xpert HIV-1 Qual and m-PIMA HIV 1/2 detect for early diagnosis of HIV-1 and HIV-2 in Senegal.
Topics: Child; Early Diagnosis; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant; Infant, Newborn; Infec | 2022 |
Validation of the point-of-care (POC) technologies Xpert HIV-1 Qual and m-PIMA HIV 1/2 detect for early diagnosis of HIV-1 and HIV-2 in Senegal.
Topics: Child; Early Diagnosis; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant; Infant, Newborn; Infec | 2022 |